Total Returns (Price + Dividend) 
Citurgia Biochem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
Announcements 
Board Meeting Intimation for Consider And Approve Unaudited Financial Results (Standalone) For The Quarter Ended June 30 2026.
04-Aug-2026 | Source : BSECiturgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Unaudited Financial Results (Standalone) for the quarter ended June 30 2026.
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
24-Jul-2026 | Source : BSEResignation of company secretary
Closure of Trading Window
30-Jun-2026 | Source : BSECLOSURE OF TRADING WINDOW
Corporate Actions 
12 Aug 2026
No Dividend history available
Citurgia Biochemicals Ltd has announced 2:10 stock split, ex-date: 26 Apr 18
No Bonus history available
No Rights history available
Quality key factors 
No Data Found
Valuation key factors
No Data Found
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 8 FIIs (0.0%)
Dev Versha Jetro Valley Private Limited (27.14%)
None
0.3%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
YoY Growth in year ended Mar 2026 is -76.19% vs 12.50% in Mar 2025